CDC Makes Recommendations for New, Preferred Shingles Vaccine

November 14, 2017

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices made three recommendations for the use of GlaxoSmithKline’s recently approved shingles vaccine, Shingrix®.

The three recommendations include the use of Shingrix for:


The U.S. Food and Drug Administration (FDA) approved Shingrix Oct. 20 for use in adults aged 50 years and older.

According to GlaxoSmithKline’s press release, the ACIP recommendations will be forwarded to the director of the CDC and the U.S. Department of Health and Human Services (HHS) for review and approval. Once approved, the final recommendations will be published in a future Morbidity and Mortality Weekly Report.